Meeting the Challenge of Change after Brexit
Despite the issues that The United Kingdom leaving the EU has wrought, Eramol is addressing change, confident in the knowledge that we can provide even better levels of service to all our customers, from right across the globe.
Our Irish facility acts as a base for EU importation, EU QP Release, and storage and distribution direct to trial sites. Over the border in Northern Ireland, trial sites also benefit from the proximity of our facility in The Irish Republic. Eramol’s United Kingdom facility provides QP Verification Services for IMPs imported from the EU.
We provide a full ‘Importer of Record’ (IOR) service into both the UK and Ireland, and QPs can give you pertinent regulatory and supply chain advice on a wide range of issues.
Change is inevitable post-Brexit, but Eramol has anticipated this new environment well and are already making strides in easing the pressures and delivering new, autonomous, solutions.
Placebo matching is a key aspect of pharmacological research, and we offer extensive, rapid and cost-effective services in the field of placebo manufacturing. We fully understand that if you are looking for a placebo to parallel your product, or designing a trial dose that matches an existing comparator, getting a good match can be challenging.
Sponsors require an end-to-end service that can provide comparator products on a global scale.
Eramol offers clinical formulation development and manufacturing services to enable you to develop your product and speed up your time to market. We’ll work with you to develop an effective formulation – either in solid tablet, capsule or liquid form - giving you optimal clinical outcomes that can support your product across all clinical trial phases.